CEO Walter Klemp highlighted the official start of the Phase 3 MIRACLE trial for Annamycin, with the first patient treated and a total of 38 sites now selected worldwide. He noted, "We just announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results